Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)

NCT04448756 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease 2019

Interventions

DRUG: M5049
DRUG: M5049
DRUG: Placebo

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]